Flavaglines: potent anticancer drugs that target prohibitins and the helicase eIF4A

By Basmadjian Christine   Thuaud Frédéric   Ribeiro Nigel   Désaubry Laurent  

Future Medicinal Chemistry, Vol. 5, Iss. 18, 2013-12 ,pp. : 2185-2197

Future Science

Access to resources Recommend Favorite

Synergistic activation of eIF4A by eIF4B and eIF4G

By Nielsen Klaus H.  

Nucleic Acids Research, Vol. 39, Iss. 7, 2011-04 ,pp. : 2678-2689

Oxford University Press

Access to resources Recommend Favorite

Effect of mRNA Cap Structure on eIF-4E Phosphorylation and Cap Binding Analyses Using Ser209-Mutated eIF-4Es

By Shibata S.   Morino S.   Tomoo K.   In Y.   Ishida T.  

Biochemical and Biophysical Research Communications, Vol. 247, Iss. 2, 1998-06 ,pp. : 213-216

Elsevier

Access to resources Recommend Favorite

eIF4G stimulates the activity of the DEAD box protein eIF4A by a conformational guidance mechanism

By Hilbert Manuel   Kebbel Fabian   Gubaev Airat   Klostermeier Dagmar  

Nucleic Acids Research, Vol. 39, Iss. 6, 2011-03 ,pp. : 2260-2270

Oxford University Press

Access to resources Recommend Favorite

Phosphorylation of eIF-4E on Ser 209 in Response to Mitogenic and Inflammatory Stimuli Is Faithfully Detected by Specific Antibodies

By Tschopp C.   Knauf U.   Brauchle M.   Zurini M.   Ramage P.   Glueck D.   New L.   Han J.   Gram H.  

Molecular Cell Biology Research Communications, Vol. 3, Iss. 4, 2000-04 ,pp. : 205-211

Academic Press

Access to resources Recommend Favorite